Webinar | Is your natural food dye compliant, shelf-stable, and ready to scale?
24th July | 12 PM ET: Register Now

CerFlux

CerFlux offers personalized medicine technology for matching treatments to tumors.
2018
11-50
Birmingham, Alabama, United States
  • Oncology (Cancer)
  • Personalized Medicine Technologies

Investment Funding

Last Funding Stage

Grant

Total Funding Amount

375.K

Last Funding Amount

275.K

Last Funding Date

03-08-2023

Lead Investors

National Science Foundation, Innovate Alabama

Revenue

$1M to $10M

People

Founders

About

CerFlux offers personalized medicine technology for matching treatments to tumors that aim to improve outcomes and quality of life while reducing the time, the pain, and the cost of cancer treatment.

Something missing or incorrect on this page? Help us enrich this information